TVTX Earnings

TVTX reported its FY2025Q3 earnings on 2025-10-30, showcasing a revenue of 164.86M against an estimate of 106.09M, resulting in a 55.4% surprise. The EPS was 0.59, surpassing the expected -0.09 by 755.56%. The stock experienced a 18.58% price change on the earnings day and a 13.73% change over the next five days, reflecting market reactions to the results.

Following TVTX's FY2025Q3 earnings announcement on 2025-10-30, the stock price moved by 18.58% on the day of the release. Over the subsequent five days, it saw a 13.73% change. Historically, TVTX's stock price tends to shift by an average of -5.67% in the 10 days leading up to earnings and -4.9% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate TVTX's annual revenue to reach 133.51M, while the EPS is projected at 0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TVTX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TVTX's stock price typically moves by -5.67% in the 10 days before its earnings and -4.9% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.07 and revenue of 133.51M.

The earnings call highlights strong financial performance and strategic growth opportunities, particularly with FILSPARI's expanding market presence and potential FSGS approval. The Q&A section reinforced confidence in the company's strategies and market positioning, with positive insights on FILSPARI's growth potential and FDA interactions. Despite some uncertainties in FDA requests and specific metrics, the overall sentiment remains positive due to robust market opportunities and strategic plans.